Xiaodong Wang is Director at BeiGene, Ltd. (BGNE). They have made 44 open-market trades across 1 company since 2016, most recently 2026-10-13.
CIK 0001662982
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 44 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONC | SELL · 10b5-1 | 2026-10-13 | 2026-10-15 | $350.99 | $10.9M | — | — | — |
| ONC | SELL · 10b5-1 | 2026-09-28 | 2026-09-30 | $364.79 | $11.3M | -4.8% | — | — |
| ONC | SELL · 10b5-1 | 2026-09-08 | 2026-09-10 | $349.10 | $13.4M | +7.1% | +2.1% | — |
| ONC | SELL · 10b5-1 | 2025-06-24 | 2025-06-25 | $265.72 | $668K | -7.0% | +10.9% | +25.2% |
| ONC | SELL · 10b5-1 | 2025-06-10 | 2025-06-12 | $262.81 | $21.9M | -0.7% | -6.3% | +16.7% |
| BGNE | SELL · 10b5-1 | 2025-05-13 | 2025-05-15 | $223.49 | $18.6M | N/A | N/A | N/A |
| BGNE | SELL · 10b5-1 | 2025-04-14 | 2025-04-16 | $242.66 | $20.3M | N/A | N/A | N/A |
| BGNE | SELL · 10b5-1 | 2025-03-18 | 2025-03-20 | $261.29 | $21.8M | N/A | N/A | N/A |
| BGNE | SELL · 10b5-1 | 2025-03-04 | 2025-03-06 | $255.00 | $3.5M | N/A | N/A | N/A |
| BGNE | SELL · 10b5-1 | 2025-02-04 | 2025-02-06 | $225.83 | $14.3M | N/A | N/A | N/A |
| BGNE | SELL · 10b5-1 | 2025-01-07 | 2025-01-08 | $176.50 | $14.7M | N/A | N/A | N/A |
| BGNE | SELL · 10b5-1 | 2024-12-10 | 2024-12-12 | $186.93 | $13.7M | +2.5% | N/A | N/A |
| BGNE | SELL · 10b5-1 | 2024-11-26 | 2024-11-29 | $190.20 | $16.7M | -14.2% | -14.5% | N/A |
| BGNE | SELL | 2023-03-08 | 2023-03-10 | $226.11 | $29.7M | -0.2% | +8.8% | +0.5% |
| BGNE | SELL | 2023-01-12 | 2023-01-17 | $260.52 | $2.6M | -4.5% | -13.5% | -2.7% |
| BGNE | SELL | 2023-01-09 | 2023-01-11 | $251.71 | $1.5M | +3.8% | -4.9% | -2.0% |
| BGNE | SELL | 2022-12-13 | 2022-12-15 | $211.32 | $1.3M | +7.1% | +30.7% | +15.2% |
| BGNE | SELL | 2022-11-15 | 2022-11-17 | $210.14 | $835K | -3.2% | +1.6% | +20.6% |
| BGNE | SELL | 2022-08-05 | 2022-08-09 | $197.38 | $4.5M | -7.7% | -11.7% | +1.8% |
| BGNE | SELL | 2021-11-08 | 2021-11-10 | $349.69 | $2.2M | -2.8% | -18.2% | -42.1% |
| BGNE | SELL | 2021-11-08 | 2021-11-10 | $349.93 | $1.8M | -2.8% | -18.2% | -42.1% |
| BGNE | SELL | 2021-07-01 | 2021-07-01 | $348.43 | $2.4M | -4.7% | -6.3% | +3.5% |
| BGNE | SELL | 2021-05-10 | 2021-05-12 | $300.66 | $1.7M | +9.0% | +10.2% | +0.2% |
| BGNE | SELL | 2020-10-16 | 2020-10-20 | $320.00 | $1.6M | -1.2% | -6.0% | +18.9% |
| BGNE | SELL | 2020-10-05 | 2020-10-07 | $300.00 | $1.5M | +0.4% | -2.3% | -10.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.